BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 26225736)

  • 1. Stealth monoolein-based nanocarriers for delivery of siRNA to cancer cells.
    Oliveira AC; Raemdonck K; Martens T; Rombouts K; Simón-Vázquez R; Botelho C; Lopes I; Lúcio M; González-Fernández Á; Real Oliveira ME; Gomes AC; Braeckmans K
    Acta Biomater; 2015 Oct; 25():216-29. PubMed ID: 26225736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dioctadecyldimethylammonium:monoolein nanocarriers for efficient in vitro gene silencing.
    Oliveira AC; Martens TF; Raemdonck K; Adati RD; Feitosa E; Botelho C; Gomes AC; Braeckmans K; Real Oliveira ME
    ACS Appl Mater Interfaces; 2014 May; 6(9):6977-89. PubMed ID: 24712543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoolein-based nanocarriers for enhanced folate receptor-mediated RNA delivery to cancer cells.
    Lopes I; C N Oliveira A; P Sárria M; P Neves Silva J; Gonçalves O; Gomes AC; Real Oliveira ME
    J Liposome Res; 2016 Sep; 26(3):199-210. PubMed ID: 26340109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tunable pDNA/DODAB:MO lipoplexes: the effect of incubation temperature on pDNA/DODAB:MO lipoplexes structure and transfection efficiency.
    Silva JP; Oliveira AC; Lúcio M; Gomes AC; Coutinho PJ; Oliveira ME
    Colloids Surf B Biointerfaces; 2014 Sep; 121():371-9. PubMed ID: 25023903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DODAB:monoolein-based lipoplexes as non-viral vectors for transfection of mammalian cells.
    Silva JP; Oliveira AC; Casal MP; Gomes AC; Coutinho PJ; Coutinho OP; Oliveira ME
    Biochim Biophys Acta; 2011 Oct; 1808(10):2440-9. PubMed ID: 21787746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid-based Nanocarriers for siRNA Delivery: Challenges, Strategies and the Lessons Learned from the DODAX: MO Liposomal System.
    Oliveira ACN; Fernandes J; Gonçalves A; Gomes AC; Oliveira MECDR
    Curr Drug Targets; 2019; 20(1):29-50. PubMed ID: 29968536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity.
    Belletti D; Tosi G; Forni F; Lagreca I; Barozzi P; Pederzoli F; Vandelli MA; Riva G; Luppi M; Ruozi B
    Eur J Pharm Biopharm; 2016 Feb; 99():7-17. PubMed ID: 26625717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural dynamics and physicochemical properties of pDNA/DODAB:MO lipoplexes: effect of pH and anionic lipids in inverted non-lamellar phases versus lamellar phases.
    Silva JP; Oliveira IM; Oliveira AC; Lúcio M; Gomes AC; Coutinho PJ; Oliveira ME
    Biochim Biophys Acta; 2014 Oct; 1838(10):2555-67. PubMed ID: 24976292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small interfering RNA delivery into the liver by cationic cholesterol derivative-based liposomes.
    Hattori Y; Machida Y; Honda M; Takeuchi N; Yoshiike Y; Ohno H; Onishi H
    J Liposome Res; 2017 Dec; 27(4):264-273. PubMed ID: 27345333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poly(vinyl pyrrolidone) derivatives as PEG alternatives for stealth, non-toxic and less immunogenic siRNA-containing lipoplex delivery.
    Berger M; Toussaint F; Djemaa SB; Laloy J; Pendeville H; Evrard B; Jerôme C; Lechanteur A; Mottet D; Debuigne A; Piel G
    J Control Release; 2023 Sep; 361():87-101. PubMed ID: 37482343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effect of antigen delivery using monoolein-based liposomes in experimental hematogenously disseminated candidiasis.
    Carneiro C; Correia A; Lima T; Vilanova M; Pais C; Gomes AC; Real Oliveira MECD; Sampaio P
    Acta Biomater; 2016 Jul; 39():133-145. PubMed ID: 27150234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PEGylation of lipoplexes: The right balance between cytotoxicity and siRNA effectiveness.
    Lechanteur A; Furst T; Evrard B; Delvenne P; Hubert P; Piel G
    Eur J Pharm Sci; 2016 Oct; 93():493-503. PubMed ID: 27593989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stealth, biocompatible monoolein-based lyotropic liquid crystalline nanoparticles for enhanced aloe-emodin delivery to breast cancer cells: in vitro and in vivo studies.
    Freag MS; Elnaggar YS; Abdelmonsif DA; Abdallah OY
    Int J Nanomedicine; 2016; 11():4799-4818. PubMed ID: 27703348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poly(N-methyl-N-vinylacetamide): A Strong Alternative to PEG for Lipid-Based Nanocarriers Delivering siRNA.
    Berger M; Toussaint F; Ben Djemaa S; Maquoi E; Pendeville H; Evrard B; Jerôme C; Leblond Chain J; Lechanteur A; Mottet D; Debuigne A; Piel G
    Adv Healthc Mater; 2024 Mar; 13(8):e2302712. PubMed ID: 37994483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The diffusion-driven microfluidic process to manufacture lipid-based nanotherapeutics with stealth properties for siRNA delivery.
    Eş I; Malfatti-Gasperini AA; de la Torre LG
    Colloids Surf B Biointerfaces; 2022 Jul; 215():112476. PubMed ID: 35390597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid-based nanoparticles for siRNA delivery in cancer therapy: paradigms and challenges.
    Gomes-da-Silva LC; Fonseca NA; Moura V; Pedroso de Lima MC; Simões S; Moreira JN
    Acc Chem Res; 2012 Jul; 45(7):1163-71. PubMed ID: 22568781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. siRNA delivery to lung-metastasized tumor by systemic injection with cationic liposomes.
    Hattori Y; Nakamura A; Arai S; Kawano K; Maitani Y; Yonemochi E
    J Liposome Res; 2015; 25(4):279-86. PubMed ID: 25543847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel dendritic nanocarrier of polyamidoamine-polyethylene glycol-cyclic RGD for "smart" small interfering RNA delivery and in vitro antitumor effects by human ether-à-go-go-related gene silencing in anaplastic thyroid carcinoma cells.
    Li G; Hu Z; Yin H; Zhang Y; Huang X; Wang S; Li W
    Int J Nanomedicine; 2013; 8():1293-306. PubMed ID: 23569377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation of PEGylated cationic nanoliposome-siRNA complexes for cancer therapy.
    Haghiralsadat F; Amoabediny G; Naderinezhad S; Forouzanfar T; Helder MN; Zandieh-Doulabi B
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):684-692. PubMed ID: 29475393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Convenient targeting of stealth siRNA-lipoplexes to cells with chelator lipid-anchored molecules.
    Herringson TP; Altin JG
    J Control Release; 2009 Nov; 139(3):229-38. PubMed ID: 19595724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.